MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 1, 2008; DOI: 10.1124/mol.108.045674


0026-895X/08/7401-9-19$20.00
Mol Pharmacol 74:9-19, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.045674v1
74/1/9    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bandler, P. E.
Right arrow Articles by Deeley, R. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bandler, P. E.
Right arrow Articles by Deeley, R. G.

Identification of Regions Required for Apical Membrane Localization of Human Multidrug Resistance Protein 2

Paul E. Bandler1, Christopher J. Westlake2, Caroline E. Grant, Susan P. C. Cole, and Roger G. Deeley

Division of Cancer Biology and Genetics (P.E.B., C.J.W., C.E.G., S.P.C.C., R.G.D.), and Departments of Pathology and Molecular Medicine (P.E.B., C.E.G., S.P.C.C., R.G.D.) and Biochemistry (C.J.W., R.G.D.), Queen's University Cancer Research Institute, Kingston, Ontario, Canada

Multidrug resistance proteins MRP1 and MRP2 transport a wide range of endo- and xenobiotics. However, with the exception of certain parts of the brain, MRP1 traffics to basolateral membranes of polarized cells, whereas MRP2 is apical in location and thus it is particularly important for systemic elimination of such compounds. Different regions of MRP1 and MRP2 seem to target them to their respective membrane locations. In addition to two "core" membrane spanning domains (MSDs) characteristic of ATP-binding cassette transporters, MRP1 and MRP2 have a third NH2-terminal MSD (MSD0), which is not required for basolateral targeting of MRP1, or for transport of at least some substrates. Here, we demonstrate that all elements necessary for apical targeting of MRP2 reside in MSD0 and the adjacent cytoplasmic loop (CL) 3. Furthermore, we show that this region of MRP2 can target the core of MRP1 to an exclusively apical location. Within MRP2 CL3, we identified a lysine-rich element that is essential for apical targeting. When introduced into MRP1, this element alone is sufficient to result in partial apical localization. However, exclusive targeting to the apical membrane seems to require the integrity of the entire region encompassing MSD0 and CL3 of MRP2. Because CL3 of MRP1 is critical for binding, transport, or both of several compounds, we also examined the function of hybrids containing all, or portions of MRP2 MSD0 and CL3. Our results indicate that CL3 is important for interaction with both the glutathione and glucuronide conjugates tested, but that different regions may be involved.


Received January 28, 2008; accepted March 31, 2008

Address correspondence to: Dr. Roger G. Deeley, Division of Cancer Biology and Genetics, Queen's University Cancer Research Institute, Kingston, ON, Canada K7L 3N6. E-mail: deeleyr{at}post.queensu.ca







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics